Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Innate Pharma (IPHA) Equity Ratio (2017 - 2025)

Innate Pharma posted quarterly Equity Ratio of 0.35 for Q4 2025, down 535.05% year-on-year from 0.08 in Q4 2024, and down 725.21% on a QoQ basis from 0.06 in Q2 2025.

Innate Pharma (IPHA) has 9 years of Equity Ratio data on file, last reported at 0.35 in Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 535.05% year-over-year to 0.35; the trailing twelve-month figure through Dec 2025 stood at 0.35 (down 535.05% YoY), and the FY2025 full-year result was 0.35, down 535.05% from the prior year.
  • Equity Ratio for Q4 2025 stood at 0.35, down from 0.06 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.5 in Q2 2021 and bottomed at 0.35 in Q4 2025.
  • The 5-year median for Equity Ratio is 0.28 (2022), against an average of 0.21.
  • The widest annual swing landed in 2023, when Equity Ratio gained 13.72%; it then plunged 535.05% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.4 in 2021, then sank by 35.14% to 0.26 in 2022, then gained by 13.72% to 0.3 in 2023, then plunged by 73.15% to 0.08 in 2024, then slumped by 535.05% to 0.35 in 2025.
  • The last three Equity Ratio figures came in at 0.35 (Q4 2025), 0.06 (Q2 2025), and 0.08 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 0.04
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 0.42
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 0.73
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 0.77
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 0.21
10 Innate Pharma 199.64 Mn 199.64 Mn - -0.35

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -0.35
Jun 30, 2025 0.06
Dec 31, 2024 0.08
Jun 30, 2024 0.19
Dec 31, 2023 0.30
Jun 30, 2023 0.29
Dec 31, 2022 0.26
Jun 30, 2022 0.41
Dec 31, 2021 0.40
Jun 30, 2021 0.50
Dec 31, 2020 0.51
Jun 30, 2020 0.62
Dec 31, 2019 0.54
Dec 31, 2018 0.37
Dec 31, 2017 0.34